share_log

SILENCE THERAPEUTICS PLC | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(5.43%),Deep Track Biotechnology Master Fund, Ltd.(5.43%), etc.

SEC ·  Feb 14 08:57
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more